Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to ...

Thousands of women are now suing pharmaceutical giant Pfizer over claims its popular birth control injection left them with ...

Pfizer announced Wednesday it has begun phases 2 and 3 of its pediatric clinical trial for Paxlovid, its COVID-19 antiviral treatment. The study will look into how effective and safe the treatment is ...

Pfizer Inc (PFE) announced an update on their ongoing clinical study.

Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted a 2028 launch. CEO Albert Bourla explained the pharma's strategy at J.P.

Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency US authorization ...

Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert ...

In today’s ACT Brief, we look at how global clinical development is evolving through decentralized models and emerging ...